R&D | February 07, 2026
£1bn London Cancer Hub expansion wins planning approval
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The state-of-the-art commercial production plant will be built on a 95-acre site in Saarlouis, acquired at the end of 2024
The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
The newly certified kits are designed for early detection and large-scale screening programs
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Subscribe To Our Newsletter & Stay Updated
